Multiple Myeloma News and Research

RSS
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bone.
Mitochondrial fission factor could represent a promising target for cancer therapy

Mitochondrial fission factor could represent a promising target for cancer therapy

Exposure to 9/11 WTC dust associated with increased risk of heart disease in NYC firefighters

Exposure to 9/11 WTC dust associated with increased risk of heart disease in NYC firefighters

Younger people getting cancer due to obesity

Younger people getting cancer due to obesity

New therapy found to be effective for patients with a particular type of bone marrow cancer

New therapy found to be effective for patients with a particular type of bone marrow cancer

Cancer survivors could be at greater risk of cardiovascular diseases

Cancer survivors could be at greater risk of cardiovascular diseases

Roswell Park receives more than $15 million in grants for cancer research

Roswell Park receives more than $15 million in grants for cancer research

UAMS Myeloma Center receives $542,486 grant from Leukemia & Lymphoma Society

UAMS Myeloma Center receives $542,486 grant from Leukemia & Lymphoma Society

Study finds new way to help cancer doctors predict blood clots in patients with multiple myeloma

Study finds new way to help cancer doctors predict blood clots in patients with multiple myeloma

Rutgers researchers create new device to see if targeted cancer therapy is working

Rutgers researchers create new device to see if targeted cancer therapy is working

AI-enabled device detects if targeted chemotherapy is working

AI-enabled device detects if targeted chemotherapy is working

Engineered stem cells offer new treatment for metastatic bone cancer

Engineered stem cells offer new treatment for metastatic bone cancer

FDA grants accelerated approval to new treatment for refractory multiple myeloma

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Have cancer, must travel: Patients left in lurch after hospital closes

Have cancer, must travel: Patients left in lurch after hospital closes

Study identifies risk factors for cardiotoxicity with relapsed multiple myeloma therapy

Study identifies risk factors for cardiotoxicity with relapsed multiple myeloma therapy

Roswell Park physician leads effort to compile new multiple myeloma imaging guidelines

Roswell Park physician leads effort to compile new multiple myeloma imaging guidelines

Drug therapy may delay onset of myeloma symptoms, finds study

Drug therapy may delay onset of myeloma symptoms, finds study

Cancer drug could be used to treat brain aneurysms, shows research

Cancer drug could be used to treat brain aneurysms, shows research

Finding potential treatments for autoimmune diseases

Finding potential treatments for autoimmune diseases

DNA rearrangement may predict poor outcomes in multiple myeloma

DNA rearrangement may predict poor outcomes in multiple myeloma

Different types of myeloma need specific criteria diagnostic criteria

Different types of myeloma need specific criteria diagnostic criteria